☆ 4.7 Article

Pharmacokinetic Study of Enteric-Coated Sustained-Release Aspirin Tablets in Healthy Chinese Participants

DRUG DESIGN DEVELOPMENT AND THERAPY (2023)

US Preventive Services Task Force Recommendation Statement on Screening for Atrial Fibrillation Reply

Karina W. Davidson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Medicine, General & Internal

Enteric-Coated Aspirin and the Risk of Gastrointestinal Side Effects: A Systematic Review

Hanan Muzeyin Kedir et al.

International Journal of General Medicine (2021)

添加到收藏夹

Article Multidisciplinary Sciences

In-vitro and in-vivo metabolism of different aspirin formulations studied by a validated liquid chromatography tandem mass spectrometry method

Michele Dei Cas et al.

Summary: A high-throughput LC-MS/MS method was validated for measuring aspirin and salicylic acid in blood and plasma. The study found differences in absorption rate and plasma AUC between oral administration of enteric-coated aspirin and plain aspirin, with higher between-subjects variability seen after enteric-coated aspirin.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Hematology

Contemporary Clinical Use of Aspirin: Mechanisms of Action, Current Concepts, Unresolved Questions, and Future Perspectives

Mikael Christiansen et al.

Summary: Aspirin is commonly used in clinical practice for acute management and secondary prevention of cardiovascular diseases, but its effectiveness in primary prevention remains uncertain. There are several unresolved issues regarding aspirin's clinical use, including optimal dosing regimens and the safety and efficacy of enteric-coated formulations.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus

Deepak L. Bhatt et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Drug Resistance and Pseudoresistance An Unintended Consequence of Enteric Coating Aspirin

Tilo Grosser et al.

CIRCULATION (2013)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Aspirin resistance and platelet turnover: A 25-year old issue

G. Di Minno

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2011)

添加到收藏夹

Pharmacokinetic Study of Enteric-Coated Sustained-Release Aspirin Tablets in Healthy Chinese Participants

相关参考文献

US Preventive Services Task Force Recommendation Statement on Screening for Atrial Fibrillation Reply

Enteric-Coated Aspirin and the Risk of Gastrointestinal Side Effects: A Systematic Review

In-vitro and in-vivo metabolism of different aspirin formulations studied by a validated liquid chromatography tandem mass spectrometry method

Contemporary Clinical Use of Aspirin: Mechanisms of Action, Current Concepts, Unresolved Questions, and Future Perspectives

Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus

Drug Resistance and Pseudoresistance An Unintended Consequence of Enteric Coating Aspirin

Aspirin resistance and platelet turnover: A 25-year old issue

导出引文

分享论文